The largest of its kind prospective cohort study of 69 men receiving stereotactic MR-guided daily adapted radiotherapy (SMART) to the prostate alone reports safety and feasibility—the million dollar question remains incremental utility. | Nugent, Adv Radiat Oncol 2024
